Your browser doesn't support javascript.
loading
Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing.
Ross, Sandra L; Sherman, Marika; McElroy, Patricia L; Lofgren, Julie A; Moody, Gordon; Baeuerle, Patrick A; Coxon, Angela; Arvedson, Tara.
Afiliación
  • Ross SL; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • Sherman M; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • McElroy PL; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • Lofgren JA; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • Moody G; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • Baeuerle PA; Department of Amgen Research Munich, Amgen Inc., Munich, Germany.
  • Coxon A; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
  • Arvedson T; Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America.
PLoS One ; 12(8): e0183390, 2017.
Article en En | MEDLINE | ID: mdl-28837681

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Anticuerpos Biespecíficos / Efecto Espectador / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Anticuerpos Biespecíficos / Efecto Espectador / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos